News
Turbine boosts AI platform to deliver cancer treatments
Turbine, a company which has developed a cell simulation platform, has completed a €20m financing round. Mercia and MSD – also known as Merck & Co in the US and Canada – Global Health Innovation (GHI) Fund co-led the financing, joined by Day One Capital and existing investors Accel, Delin Ventures and XTX Ventures.